Substantial insider ownership aligns insiders and common shareholders. Yet, recent insider selling without corresponding buying, along with non-high insider ownership, raises concerns about company's prospects, resulting in a cautious outlook.
Hudson Technologies banks on Houghton's deep industry experience and relationship-building skills for valuable insights as it aims to expand its offerings and reinforce leadership position.
$Bumble(BMBL.US)$Bumble shares are trading higher after the company reported a 29% increase in Bumble App paying users and App revenue increased 42.2% year over year. Looking for another run. $KALA BIO(KALA.US)$shares are trading higher after the company announced UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies and Cigna Medicare has added EYSUVIS as a preferred brand. $哈德森科技(HDSN.US)$Hudson Technologies shares are trading higher a...
哈德森科技股票討論區
2022前三季度營收增加79%,營業利潤則增長了2.8倍達到1.2億,淨利潤增長2.8倍到1億。
從毛利率可以看出近期毛利率從負4.4%提升到了37%,2022前3季度進一步提升到50%以上。
利潤表顯示2021年利息費用佔營業利潤的27%,2022前3季度利息費用佔營業利潤的10%,改進不是利息變少了,而是利潤變高了。
5年來資產負債率從61.6%提升到74.9%後下降到67.1%,2022Q3下降到40.5%。
2021年存貨從4,446萬增加到9,414.4萬,增加了4968.4萬,遠超當年淨利潤3225.9萬,佔營收的50%,不是個好現象。2022Q3存貨進一步提升到了1.2億,增加了近6千萬,而前3季度的營收僅有8,950.2萬。
5年來累計經營淨額也遠低於投資淨額,而且近3年不斷下降。
目前市盈率15.7,市盈率T...
• $APi Group(APG.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $23
• $Axos Financial(AX.US)$ : KBW Upgrades to Outperform from Marketperform - PT $56 (from $52)
• $美國銀行(BAC.US)$: Societe Generale Upgrades to Buy from Hold - PT $37.50 (from $40.50)
• $Element Solutions(ESI.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $22 (from $24)
• $Fate Therapeutics(FATE.US)$ : BMO Capital Upgrades...
業績很好的公司,大盤迴調只有業績好的公司是最硬的,夏季來臨,做爲空調製冷公司業務會進入旺季,預計全年業績會更好。
$KALA BIO(KALA.US)$ shares are trading higher after the company announced UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies and Cigna Medicare has added EYSUVIS as a preferred brand.
$哈德森科技(HDSN.US)$ Hudson Technologies shares are trading higher a...
Positions Details
加載中...
暫無評論